Skip to main content
PMC home page
AAPS PharmSciTech logoLink to AAPS PharmSciTech
. 2006 Sep 8;7(3):E143–E151. doi: 10.1208/pt070374

Cross-linked guar gum microspheres: A viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer

Mohini Chaurasia 1, Manish K Chourasia 2, Nitin K Jain 1, Aviral Jain 1, Vandana Soni 1, Yashwant Gupta 1, Sanjay K Jain 1,✉
PMCID: PMC2750516  PMID: 17025254

Abstract

In the present work, guar gum microspheres containing methotrexate (MTX) were prepared and characterized for local release of drug in the colon, which is a prerequisite for the effective treatment of colorectal cancer. Guar gum microspheres were prepared by the emulsification method using glutaraldehyde as a cross-linking agent. Surface morphological characteristics were investigated using scanning electron microscopy. Particle size, shape, and surface morphology were significantly affected by guar gum concentration, glutaral dehyde concentration, emulsifier concentration (Span 80), stirring rate, stirring time, and operating temperature. MTX-loaded microspheres demonstrated high entrapment efficiency (75.7%). The in vitro drug release was investigated using a US Pharmacopeia paddle type (type II) dissolution rate test apparatus in different media (phosphate-buffered saline [PBS], gastrointestinal fluid of different pH, and rat cecal content release medium), which was found to be affected by a change to the guar gum concentration and glutaraldehyde concentration. The drug release in PBS (pH 7.4) and simulated gastric fluids followed a similar pattern and had a similar release rate, while a significant increase in percent cumulative drug release (91.0%) was observed in the medium containing rat cecal content. In in vivo studies, guar gum microspheres delivered most of their drug load (79.0%) to the colon, whereas plain drug suspensions could deliver only 23% of their total dose to the target site. Guar gum microspheres showed adequate potential in achieving local release of drug in in vitro release studies, and this finding was further endorsed with in vivo studies.

Keywords: Polysaccharides for colon drug delivery, NDDS, guar gum microspheres, methotrexate, colorectal cancer, glutaraldehyde cross-linking

Full Text

The Full Text of this article is available as a PDF (388.0 KB).

References

  • 1.Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. 2002;132:2350S–2355S. doi: 10.1093/jn/132.8.2350S. [DOI] [PubMed] [Google Scholar]
  • 2.Giovannucci E. Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. J Nutr. 2004;134:2475S–2481S. doi: 10.1093/jn/134.9.2475S. [DOI] [PubMed] [Google Scholar]
  • 3.Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science. 1992;256:102–105. doi: 10.1126/science.1566048. [DOI] [PubMed] [Google Scholar]
  • 4.Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Schoetz DJ. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med. 2002;346:311–320. doi: 10.1056/NEJMoa012294. [DOI] [PubMed] [Google Scholar]
  • 5.Calabresi P, Chabner BA. Chemotherapy of neoplastic diseases. In: Hardman JG, Limbird LE, Perry BM, Raymond WR, editors. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. New Delhi, India: McGraw-Hill; 1996. pp. 1381–1388. [Google Scholar]
  • 6.Michor F, Iwasa Y, Lengauer C, Nowak NA. Dynamics of colorectal cancer. Semin Cancer Biol. 2005;15:484–493. doi: 10.1016/j.semcancer.2005.06.005. [DOI] [PubMed] [Google Scholar]
  • 7.Krishnaiah YSR, Satyanarayan S. Colon-specific drug delivery systems. In: Jain NK, editor. Advances in Controlled and Novel Drug Delivery. New Delhi, India: CBS Publishers and Distributors; 2001. pp. 89–119. [Google Scholar]
  • 8.Ciftci K, Groves MJ. Delivery of antitumor compounds to the rat colon: in vitro and in vivo evaluation. Int J Pharm. 1996;145:157–164. doi: 10.1016/S0378-5173(96)04764-3. [DOI] [Google Scholar]
  • 9.Levine DS, Raisys VA, Aindardi V. Coating of oral beclomethasone dipropionate capsules with cellulose acetate phthalate enhances delivery of topically active anti-inflammatory drug to the terminal ileum. Gastroenterology. 1987;92:1037–1044. doi: 10.1016/0016-5085(87)90980-2. [DOI] [PubMed] [Google Scholar]
  • 10.Rasmussen SN, Bondesen S, Hvidberg EF, et al. 5-Aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans. Gastroenterology. 1982;83:1062–1070. [PubMed] [Google Scholar]
  • 11.Lamprecht A, Yamamoto H, Takeuchi H, Kawashima Y. Observations in simultaneous microencapsulation of 5-fluorouracil and leucovorin for combined pH-dependent release. Eur J Pharm Biopharm. 2005;59:367–371. doi: 10.1016/j.ejpb.2004.09.005. [DOI] [PubMed] [Google Scholar]
  • 12.Rodriguez M, Vila-Jato JL, Torres D. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release. 1998;55:67–77. doi: 10.1016/S0168-3659(98)00029-7. [DOI] [PubMed] [Google Scholar]
  • 13.Chourasia MK, Jain SK. Design and development of multiparticulate system for targeted drug delivery to colon. Drug Deliv. 2004;11:201–207. doi: 10.1080/10717540490445955. [DOI] [PubMed] [Google Scholar]
  • 14.Klotz U. Clinical pharmacokinetics of sulphasalazine, its metabolites and other products of 5-aminosalicylic acid. Clin Pharmacokinet. 1985;10:285–302. doi: 10.2165/00003088-198510040-00001. [DOI] [PubMed] [Google Scholar]
  • 15.Chourasia MK, Jain SK. Polysaccharides for colon targeted drug delivery. Drug Deliv. 2004;11:129–148. doi: 10.1080/10717540490280778. [DOI] [PubMed] [Google Scholar]
  • 16.Sinha VR, Kumria R. Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs. Drugs Today (Barc) 1999;35:537–580. doi: 10.1358/dot.1999.35.7.548266. [DOI] [PubMed] [Google Scholar]
  • 17.Goldstein AM, Alter EN, Seaman JK. Guar gum. In: Whistler RL, editor. Industrial gums, polysaccharides and their derivatives. New York, NY: Academic Press; 1993. pp. 303–321. [Google Scholar]
  • 18.Ramaprasad YV, Krishaniah YSR, Satyanarayana S. Trends in colonic drug delivery: a review. Indian Drugs. 1995;33:1–10. [Google Scholar]
  • 19.Chourasia MK, Jain SK. Potential of guar gum microspheres for target specific drug release to colon. J Drug Target. 2004;12:435–442. doi: 10.1080/10611860400006604. [DOI] [PubMed] [Google Scholar]
  • 20.Wong TW, Chan LW, Lee HY, Heng PW. Release characteristics of pectin microspheres prepared by an emulsification technique. J Microencapsul. 2002;19:511–522. doi: 10.1080/02652040210140481. [DOI] [PubMed] [Google Scholar]
  • 21.Alkaysi HN, Gharaibeh AM, Salem MA. High-performance liquid chromatographic determination of methotrexate in plasma. Ther Drug Monit. 1990;12:191–194. doi: 10.1097/00007691-199003000-00014. [DOI] [PubMed] [Google Scholar]
  • 22.Mooter G, Kinget R. Oral colon-specific drug delivery: a review. Drug Deliv. 1995;2:81–93. doi: 10.3109/10717549509031355. [DOI] [Google Scholar]
  • 23.Krishnaiah YSR, Satyanarayana V, Dinesh Kumar B, Karthikeyan RS. in vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil. Eur J Pharm Sci. 2002;16:185–192. doi: 10.1016/S0928-0987(02)00081-7. [DOI] [PubMed] [Google Scholar]
  • 24.Deasy PB. Microencapsulation and Related Drug Processes. New York, NY: Marcel Dekker; 1984. [Google Scholar]
  • 25.Sinha VR, Mittal BR, Bhutani KK, Kumria R. Colonic drug delivery of 5-fluorouracil: an in vitro evaluation. Int J Pharm. 2004;269:101–108. doi: 10.1016/j.ijpharm.2003.09.036. [DOI] [PubMed] [Google Scholar]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES